BACKGROUND: Although several studies have explored the genetic polymorphisms of apolipoprotein E (APOE) and their impact on premature coronary artery disease (PCAD), there is still some controversy regarding the significance of their association. Our aim is to estimate the association between APOE polymorphisms and PCAD via meta-analysis. METHODS: All relevant case-control studies and cohort studies published in Chinese or English prior to March 2016 were searched for in electronic databases. Detailed information concerning each piece of literature was independently extracted by two researchers. We used STATA11.0 to process all data and to determine the pooled odds ratio (OR). Altogether, four genetic models were applied to calculate OR and 95% confidence interval (CI): (1) ε2 allele vs. ε3 allele; (2) ε2 carriers vs. ε3/3; (3) ε4 allele vs. ε3 allele; (4) ε4 carriers vs. ε3/3. RESULTS: Eighteen studies concerning APOE polymorphisms and their impact on PCAD were included in the final analysis. The pooled analysis displayed that the ε2 allele and ε2 carriers increased the risk of PCAD significantly among Asians (OR 1.54; 95% CI, 1.09-2.17; OR 1.65; 1.10-2.47), while they showed protective effects on PCAD in Caucasians (OR 0.77; 95% CI, 0.62-0.95; OR 0.69; 0.54-0.89). Subjects with the ε4 allele and ε4 carriers showed significant associations with PCAD (OR 1.62; 95% CI, 1.27-2.06; OR 1.65; 1.27-2.15). CONCLUSIONS: Our investigation supported the fact that the ε2 allele in APOE may appear as a risk factor for PCAD in Asians while a protective factor in Caucasians and that the ε4 allele acted as a genetic risk factor for PCAD.
BACKGROUND: Although several studies have explored the genetic polymorphisms of apolipoprotein E (APOE) and their impact on premature coronary artery disease (PCAD), there is still some controversy regarding the significance of their association. Our aim is to estimate the association between APOE polymorphisms and PCAD via meta-analysis. METHODS: All relevant case-control studies and cohort studies published in Chinese or English prior to March 2016 were searched for in electronic databases. Detailed information concerning each piece of literature was independently extracted by two researchers. We used STATA11.0 to process all data and to determine the pooled odds ratio (OR). Altogether, four genetic models were applied to calculate OR and 95% confidence interval (CI): (1) ε2 allele vs. ε3 allele; (2) ε2 carriers vs. ε3/3; (3) ε4 allele vs. ε3 allele; (4) ε4 carriers vs. ε3/3. RESULTS: Eighteen studies concerning APOE polymorphisms and their impact on PCAD were included in the final analysis. The pooled analysis displayed that the ε2 allele and ε2 carriers increased the risk of PCAD significantly among Asians (OR 1.54; 95% CI, 1.09-2.17; OR 1.65; 1.10-2.47), while they showed protective effects on PCAD in Caucasians (OR 0.77; 95% CI, 0.62-0.95; OR 0.69; 0.54-0.89). Subjects with the ε4 allele and ε4 carriers showed significant associations with PCAD (OR 1.62; 95% CI, 1.27-2.06; OR 1.65; 1.27-2.15). CONCLUSIONS: Our investigation supported the fact that the ε2 allele in APOE may appear as a risk factor for PCAD in Asians while a protective factor in Caucasians and that the ε4 allele acted as a genetic risk factor for PCAD.
Authors: Juho-Pekka Karjalainen; Nina Mononen; Nina Hutri-Kähönen; Miikael Lehtimäki; Mika Hilvo; Dimple Kauhanen; Markus Juonala; Jorma Viikari; Mika Kähönen; Olli Raitakari; Reijo Laaksonen; Terho Lehtimäki Journal: J Lipid Res Date: 2019-07-03 Impact factor: 5.922
Authors: Nicholas W S Chew; Bryan Chong; Cheng Han Ng; Gwyneth Kong; Yip Han Chin; Wang Xiao; Mick Lee; Yock Young Dan; Mark D Muthiah; Roger Foo Journal: Front Genet Date: 2022-08-10 Impact factor: 4.772
Authors: Mohammad Yaser Anwar; Antoine R Baldassari; Hannah G Polikowsky; Colleen M Sitlani; Heather M Highland; Nathalie Chami; Hung-Hsin Chen; Mariaelisa Graff; Annie Green Howard; Su Yon Jung; Lauren E Petty; Zhe Wang; Wanying Zhu; Steven Buyske; Iona Cheng; Robert Kaplan; Charles Kooperberg; Ruth J F Loos; Ulrike Peters; Joseph B McCormick; Susan P Fisher-Hoch; Christy L Avery; Kira C Taylor; Jennifer E Below; Kari E North Journal: BMC Med Genomics Date: 2022-09-10 Impact factor: 3.622
Authors: Na Zhao; Yingxue Ren; Yu Yamazaki; Wenhui Qiao; Fuyao Li; Lindsey M Felton; Siamak Mahmoudiandehkordi; Alexandra Kueider-Paisley; Berkiye Sonoustoun; Matthias Arnold; Francis Shue; Jiaying Zheng; Olivia N Attrebi; Yuka A Martens; Zonghua Li; Ligia Bastea; Axel D Meneses; Kai Chen; J Will Thompson; Lisa St John-Williams; Masaya Tachibana; Tomonori Aikawa; Hiroshi Oue; Lucy Job; Akari Yamazaki; Chia-Chen Liu; Peter Storz; Yan W Asmann; Nilüfer Ertekin-Taner; Takahisa Kanekiyo; Rima Kaddurah-Daouk; Guojun Bu Journal: Neuron Date: 2020-03-20 Impact factor: 18.688
Authors: Flavio M Ceci; Mauro Ceccanti; Carla Petrella; Mario Vitali; Marisa P Messina; George N Chaldakov; Antonio Greco; Massimo Ralli; Marco Lucarelli; Antonio Angeloni; Marco Fiore; Giampiero Ferraguti Journal: Curr Neurovasc Res Date: 2021 Impact factor: 1.990